Article Type
Changed
Mon, 07/23/2018 - 10:40
Display Headline
Improved outcomes in nephrotic syndrome
Article PDF
Author and Disclosure Information

Gerald B. Appel, MD
Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Address: Gerald B. Appel, MD, Presbyterian Hospital, 622 West 168th Street, Room 4124, New York, NY 10032

The author indicates that he has been a speaker and a consultant for and has received research support from the Merck, Pfizer, AstraZeneca, Bristol-Myers Squib, Aspreva, Novartis, Roche, and Genentech corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 73(2)
Publications
Topics
Page Number
161-167
Sections
Author and Disclosure Information

Gerald B. Appel, MD
Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Address: Gerald B. Appel, MD, Presbyterian Hospital, 622 West 168th Street, Room 4124, New York, NY 10032

The author indicates that he has been a speaker and a consultant for and has received research support from the Merck, Pfizer, AstraZeneca, Bristol-Myers Squib, Aspreva, Novartis, Roche, and Genentech corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Author and Disclosure Information

Gerald B. Appel, MD
Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Address: Gerald B. Appel, MD, Presbyterian Hospital, 622 West 168th Street, Room 4124, New York, NY 10032

The author indicates that he has been a speaker and a consultant for and has received research support from the Merck, Pfizer, AstraZeneca, Bristol-Myers Squib, Aspreva, Novartis, Roche, and Genentech corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(2)
Issue
Cleveland Clinic Journal of Medicine - 73(2)
Page Number
161-167
Page Number
161-167
Publications
Publications
Topics
Article Type
Display Headline
Improved outcomes in nephrotic syndrome
Display Headline
Improved outcomes in nephrotic syndrome
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media